Gene therapy is currently undergoing clinical trials to evaluate its effectiveness at treating sickle cell disease. In this talk, Dr. Suchi Pandey will review how gene therapy is currently being used to treat sickle cell disease, the different kinds of gene therapy options being evaluated, and the potential impact to transfusion requirements before, during and after the treatment. Dr. Suchi Pandey is currently one of Stanford Blood Center's Chief Medical Officers. Her responsibilities include providing medical support to blood center staff, management of blood donor medical issues, development of blood center medical policy, oversight of blood center operations, consultation with Stanford Hospital for patient management and the teaching/supervision of fellows and residents. She is currently also one of the blood center’s CLIA Lab Directors. Dr. Pandey received an MD from Drexel University’s College of Medicine in Philadelphia. She did her residency in Anatomic and Clinical Pathology at the University of California, San Diego, and completed a one-year Transfusion Medicine fellowship at the University of California, San Francisco and Blood Centers of the Pacific. She is Board Certified in Anatomic & Clinical Pathology and in Transfusion Medicine. Before joining the Stanford Blood Center team, Dr. Pandey spent eight years as the Chief Medical Officer at Blood Centers of the Pacific and two years as an Assistant Medical Director in the UCSF Transfusion Service. Dr. Pandey is actively involved in the transfusion medicine community and currently serves on the board of the California Blood Bank Society. She is also co-chair of the Blood Center of California’s Medical Advisory Committee, and serves on educational committees for America’s Blood Centers and AABB. This presentation will be available on SBC’s YouTube channel at a later date. Check out some of our past Café Sci presenters on our YouTube page here: youtube.com/user/stanfordbloodcenter. Please note that the views and opinions presented at Café Scientifique do not necessarily reflect those of Stanford Blood Center.